Filing Flows

Filing Flows › Comparisons › AQST vs ETST

Aquestive Therapeutics vs Earth Science Tech: AQST and ETST compared

Aquestive Therapeutics is the larger company: $7.6M of revenue in its latest quarter (Q3 2026) against $7.3M for Earth Science Tech (Q2 FY27). Earth Science Tech is growing faster (-19% against -41% a year earlier). Earth Science Tech is more profitable, with an operating margin of 15.2% against -191.5%.

Aquestive Therapeutics vs Earth Science Tech, latest quarterAquestive Therapeutics vs Earth Science Tech, latest quarterAquestive Therapeutics (AQST)Earth Science Tech (ETST)Revenue$7.6M$7.3MRevenue growth, Y/Y-41%-19%Operating margin-191.5%15.2%Net margin-218.3%11.4%

Where the money goes: AQST and ETST

Aquestive Therapeutics (AQST) · Q3 2026

Aquestive Therapeutics, Q3 2026: revenue $7.6M (-41% year over year), operating margin -191.5%, net loss $16.5M, operating cash flow −$7.0M. The chart follows the revenue to costs, profit and cash.

Earth Science Tech (ETST) · Q2 FY27

Earth Science Tech, Q2 FY27: revenue $7.3M (-19% year over year), operating margin 15.2%, net earnings $831K, operating cash flow $138K. The chart follows the revenue to costs, profit and cash.

Aquestive Therapeutics revenue by segment, Q3 2026Aquestive Therapeutics revenue by segment, Q3 2026Manufacture and supply revenue$6.7MLicense and Royalty Revenue$824KCo-development and research fees$74K
Aquestive Therapeutics (AQST)Earth Science Tech (ETST)
Latest quarterQ3 2026Q2 FY27
Revenue$7.6M$7.3M
Revenue growth, Y/Y-41%-19%
Gross margin—69.3%
Operating margin-191.5%15.2%
Net earnings−$16.5M$831K
Net margin-218.3%11.4%
Operating cash flow−$7.0M$138K

Where the revenue comes from

Aquestive Therapeutics

Questions

Which is bigger, Aquestive Therapeutics or Earth Science Tech?

Aquestive Therapeutics is the larger company: $7.6M of revenue in its latest quarter (Q3 2026) against $7.3M for Earth Science Tech (Q2 FY27).

Is Aquestive Therapeutics or Earth Science Tech growing faster?

Earth Science Tech is growing faster (-19% against -41% a year earlier).

Which is more profitable, Aquestive Therapeutics or Earth Science Tech?

Earth Science Tech is more profitable, with an operating margin of 15.2% against -191.5%.

More: Aquestive Therapeutics earnings · how Aquestive Therapeutics makes money · Earth Science Tech earnings · how Earth Science Tech makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.